Janssen, Teva, Allergan, Endo, and Purdue – as well as several distributors – pursued in multistate investigation that follows individual AG inquiries and flurry of state, city, and county suits.
State attorneys general are expanding their investigation of opioid makers and distributors, intensifying the pressure on companies to change their sales and marketing practices.
At a Sept. 19 news conference, New York Attorney General Eric Schneiderman announced that a bipartisan coalition of 41 attorneys general had issued subpoenas to Endo International PLC, Janssen Pharmaceutical Cos., Teva Pharmaceutical Industries Ltd
EU-level joint clinical assessments conducted under the Health Technology Assessment Regulation need to be more flexible when it comes to evidence requirements, according to experts speaking at a gene and cell therapy conference.
During its first quarter earnings call, Moderna avoided criticizing vaccine policy changes, but de-emphasized its flu/COVID-19 vaccine for those under age 50 and prioritized cancer programs.
US HHS Advisor Calley Means said new pathways for root-cause treatments are part of the HHS Secretary Robert F. Kennedy Jr.’s vision for the FDA. But what most biopharma companies consider preventative medicines are not what he has in mind, nor does he seem to see those companies as part of the solution.
